A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8 + T Cell Epitopes
Xuedan He,Shiqi Zhou,Wei-Chiao Huang,Amal Seffouh,Moustafa T. Mabrouk,M. Thomas Morgan,Joaquin Ortega,Scott I. Abrams,Jonathan F. Lovell
DOI: https://doi.org/10.1021/acsnano.0c07680
IF: 17.1
2021-02-19
ACS Nano
Abstract:Short major histocompatibility complex (MHC) class I (MHC-I)-restricted peptides contain the minimal biochemical information to induce antigen (Ag)-specific CD8<sup>+</sup> cytotoxic T cell responses but are generally ineffective in doing so. To address this, we developed a cobalt–porphyrin (CoPoP) liposome vaccine adjuvant system that induces rapid particleization of conventional, short synthetic MHC-I epitopes, leading to strong cellular immune responses at nanogram dosing. Along with CoPoP (to induce particle formation of peptides), synthetic monophosphoryl lipid A (PHAD) and QS-21 immunostimulatory molecules were included in the liposome bilayer to generate the "CPQ" adjuvant system. In mice, immunization with a short MHC-I-restricted peptide, derived from glycoprotein 70 (gp70), admixed with CPQ safely generated functional, Ag-specific CD8<sup>+</sup> T cells, resulting in the rejection of multiple tumor cell lines, with durable immunity. When cobalt was omitted, the otherwise identical peptide and adjuvant components did not result in peptide binding and were incapable of inducing immune responses, demonstrating the importance of stable particle formation. Immunization with the liposomal vaccine was well-tolerated and could control local and metastatic disease in a therapeutic setting. Mechanistic studies showed that particle-based peptides were better taken up by antigen-presenting cells, where they were putatively released within endosomes and phagosomes for display on MHC-I surfaces. On the basis of the potency of the approach, the platform was demonstrated as a tool for <i>in vivo</i> epitope screening of peptide microlibraries comprising a hundred peptides.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c07680?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c07680</a>.Supporting methods; figures showing synthesis schemes, <sup>1</sup>H and <sup>13</sup>C NMR and mass spectra, HPLC traces, cryo-electron micrographs, peptide bindings to liposomes, gating results, CPQ/A5 vaccination effects, impacts of PHAD, QS-21 and antigens, optional solubility tag effects, QS-21 and antigen dosage effects, liposomes draining, vaccine injection effects at multiple sites, macrophage uptake, PoP lipids coated on silica beads, liposome/peptide complexes, A5 with 2 his-tag released, fluorescence integrity, various length impacts of A5, QS-21 and peptide dose effects, CPQ as platform, details of peptide binding, cytotoxicities, Rragc385 DNA sequencing, and antitumor efficacy; tables listing <sup>1</sup>H shifts and assignments, ICP analysis, representative UV–vis absorptions, polydispersities and ζ potentials, A5 peptides, and properties of A5 related and synthetic peptides (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c07680/suppl_file/nn0c07680_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology